Epilepsy drug dosage linked to specific birth defects
In a world first, new Australian medical research has given pregnant women with epilepsy new hope of reducing their chance of having a baby with physical birth defects.
Aug 25, 2013
0
0
In a world first, new Australian medical research has given pregnant women with epilepsy new hope of reducing their chance of having a baby with physical birth defects.
Aug 25, 2013
0
0
A multistate study led by researchers at the University of Utah has revealed that the risk for childhood cancer is moderately increased among children and young adolescents with certain types of major birth defects. Children ...
Aug 12, 2013
0
0
(Medical Xpress)—Researchers at King's have revealed the genetic basis of high-arched palate in the mouth for the first time, a discovery that could pave the way for new treatments to reverse the condition.
Jun 27, 2013
0
2
By identifying a protein that acts as a genetic modifier, scientists at Cold Spring Harbor Laboratory (CSHL) have solved the mystery of why some infants are born with a grave syndrome consisting of cleft palate and major ...
Jun 14, 2013
0
0
(Medical Xpress)—Breathing traffic pollution in early pregnancy is linked to a higher risk for certain serious birth defects, according to new research from the Stanford University School of Medicine.
Mar 29, 2013
0
0
(Medical Xpress)—The cellular cause of birth defects like cleft palates, missing teeth and problems with fingers and toes has been a tricky puzzle for scientists.
Sep 11, 2012
0
0
(HealthDay) -- There is considerable variation in the neuropsychological, behavioral, and academic outcomes of individuals with cleft lip and palate, as the outcomes are affected by developmental level, sex, and cleft type, ...
Aug 17, 2012
0
0
US regulators were expected to decide Tuesday whether to approve the second new anti-obesity drug in 13 years, Qnexa, which studies have shown may help some people lose up to 10 percent of their body weight.
Jul 17, 2012
0
0
(Medical Xpress) -- New research by medics at Trinity College Dublin suggests that folic acid plays a vital role in preventing a major birth defect. This is in addition to the established protection against neural birth defect ...
Jul 5, 2012
1
0
US regulators will decide in July whether to approve Qnexa, the first obesity drug in more than a decade, extending the initial deadline by three months, the California-based drug-maker VIVUS said.
Apr 10, 2012
0
0